采用E3结合酶KLHDC2进行小分子向蛋白质降解
Christopher M Hickey1, Katherine M Digianantonio1, Kurt Zimmermann1
1Arvinas, Inc, New Haven, CT, USA.
Nature structural & molecular biology
|January 4, 2024
概括
研究人员发现了针对KLHDC2 E3结合酶的新型小分子,使得针对治疗应用的向蛋白降解 (TPD) 成为可能. 这项工作扩展了TPD策略,利用KLHDC2进行基于PROTAC的BET家族和AR蛋白质降解.
科学领域:
- 生物化学和分子生物学
- 药物发现和开发 药物发现和开发
- 结构生物学 结构生物学
背景情况:
- 使用向蛋白质分解的仿真体 (PROTACs) 和分子剂进行向蛋白质降解 (TPD) 是一个有前途的治疗方式.
- 扩大E3结合酶的谱系对于推进TPD策略至关重要.
- KLHDC2是一种E3结合酶,有可能用于TPD应用.
研究的目的:
- 发现和描述针对E3结合酶KLHDC2.2.的小分子结合体.
- 开发基于KLHDC2的PROTAC,用于向蛋白质降解.
- 阐明KLHDC2 E3结合酶复合物的结构组合和调节.
主要方法:
- 小分子选和KLHDC2配体的生物化学表征.
- 对BET家族和AR蛋白质降解的PROTAC合成和验证.
- 生物化学结合测定,X射线晶体学和冷电子显微镜 (cryo-EM) 用于结构分析.
主要成果:
- 发现了与KLHDC2结合的新型小分子配体2.
- 成功开发基于KLHDC2的PROTACs,证明了BET家族和AR蛋白的高效降解.
- 结构洞察力揭示KLHDC2形成了一个由基质和连接体结合调节的动态四聚体.
结论:
- 通过PROTACs,KLHDC2可以有效地作为E3结合酶用于通过PROTACs向蛋白质降解.
- 已识别的KLHDC2连接体和结构数据为开发新的TPD疗法提供了基础.
- 了解KLHDC2组装动态是优化其在药物设计中的实用性的关键.
相关概念视频
Regulated Protein Degradation
7.3K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.3K
The Proteasome
8.7K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
8.7K
Export of Misfolded Proteins out of the ER
3.6K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
3.6K
Anaphase Promoting Complex
2.9K
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
2.9K
Receptor Downregulation in MVBs
2.1K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.1K


